Searching for the right medication-assisted treatment near me is the step that matters most, and it deserves more than a Google Maps search. The quality of the program you choose shapes how long you stay in treatment, and staying in treatment is what saves lives.
What MAT Actually Is (and Why Location Isn’t Everything)
According to SAMHSA, patients receiving medication-assisted treatment for opioid use disorder are 50% more likely to remain in treatment compared to those receiving no medication. That retention gap is the whole ballgame. People who stay in care recover. People who drop out face a dramatically elevated overdose risk, particularly in the first weeks after stopping.
Medication-assisted treatment uses FDA-approved medications to reduce cravings, prevent withdrawal, and block the euphoric effects of opioids. The medications work on the same receptors that opioids target, which is why they are effective where willpower alone is not. But the medication is only part of the picture. A provider located ten minutes from your house who offers no counseling, skips mental health screening, and pushes you to taper off before you are ready is a worse choice than a provider thirty minutes away who wraps medication inside a real clinical program. Proximity is a starting point. Program quality is the finish line.
The Medications Used in MAT Programs
Three medications are FDA-approved for opioid use disorder, and each works differently. Buprenorphine, often prescribed as Suboxone (which combines buprenorphine with naloxone), is a partial opioid agonist. It activates opioid receptors enough to eliminate withdrawal and craving without producing the same high. If you want a deeper look at how it works specifically, the mechanics behind buprenorphine treatment are worth understanding before you call a provider.
Methadone is a full opioid agonist dispensed through federally certified opioid treatment programs. It requires daily clinic visits, at least initially, and is most appropriate for patients with severe, long-duration dependence. Naltrexone (sold as Vivitrol as an extended-release injection) is an opioid antagonist: it blocks receptors entirely, making opioids ineffective. It requires a patient to be fully detoxed before starting, which creates a real barrier for many people.
A 2020 New England Journal of Medicine study comparing buprenorphine and extended-release naltrexone found that both were comparably effective once patients were inducted, but naltrexone had significantly lower induction rates because completing detox first is genuinely difficult. Knowing which medication a provider offers before you call tells you whether their program actually fits your situation.
What to Look for in a Local MAT Provider
Licensing and Accreditation
SAMHSA’s 2022 National Survey of Substance Abuse Treatment Services found that accredited facilities report consistently better patient retention and lower rates of unplanned discharge. State licensing and accreditation through bodies like CARF or The Joint Commission (JCAHO) mean the program has been reviewed against clinical standards, not just opened and left to run.
What this means in practice: ask any provider directly whether they are state-licensed and whether the facility holds CARF or JCAHO accreditation. If a provider hesitates or cannot answer clearly, that is your answer. Make that one question your first call.
Counseling and Wraparound Support
A 2021 study in the Journal of Substance Abuse Treatment examining integrated care outcomes found that patients receiving both MAT and behavioral counseling showed significantly better long-term recovery outcomes than those on medication alone. The mechanism is straightforward: opioid use disorder affects behavior, relationships, and mental health alongside physiology. Medication stabilizes the body. Counseling addresses everything else.
Programs worth your time offer individual counseling as part of the core program, not as a separate referral you have to chase down yourself. Mental health support, case management, and help navigating practical barriers like transportation or pharmacy access are signs of a program built around you as a person. Before committing, ask directly: is individual counseling included, or do you have to arrange it separately?
Insurance Acceptance and Cost Transparency
According to KFF, cost remains one of the top reported barriers to entering addiction treatment in the United States. In Maryland, Medicaid covers MAT, including the medication, prescriber visits, and counseling. That coverage exists so cost does not have to be the reason someone delays or skips care. Commercial insurance plans also cover MAT under federal parity law, and some providers offer self-pay options for patients without coverage.
The concrete step here is simple: before your first appointment, ask the provider for a plain-language breakdown of what your insurance covers and what you will owe out of pocket. A good program gives you a clear answer. Understanding what full MAT care looks like in Maryland helps you know what to expect from that conversation.
Red Flags to Avoid When Choosing a MAT Program
A 2019 study published in Substance Abuse found that programs lacking integrated mental health screening had dropout rates nearly twice as high as those with standardized intake assessments. That single omission predicts poor outcomes reliably.
Three red flags tell you a program is not built around patient success. First: no mental health screening at intake. Opioid use disorder and co-occurring mental health conditions appear together frequently, and skipping that screening means the program is not treating the whole picture. Second: medication-only care with no counseling component. Prescribing without behavioral support is not a treatment program, it is a prescription service. Third: pressure to taper off medication on an arbitrary timeline, rather than based on your clinical progress. How a real MAT program is structured gives you a baseline for comparison.
Write down two questions before you make your first call: “Do you conduct a mental health screening at intake?” and “Is individual counseling included in the program?” The answers tell you almost everything you need to know.
How Telehealth Has Changed MAT Access
A 2023 study in JAMA Network Open analyzing buprenorphine initiation data from 2020 to 2022 found that telehealth-initiated MAT produced retention rates comparable to in-person care, with significantly lower barriers to starting treatment. Federal rule changes following 2020 made it possible to begin and maintain buprenorphine treatment without an in-person visit for many patients, removing one of the most common practical obstacles.
For patients in Maryland, this matters directly. If transportation, work hours, or childcare make in-person visits difficult, telehealth intake is a real option, but not every provider offers it. When you call, ask specifically whether they accept telehealth for both the initial intake and ongoing visits. Programs that handle same-day or next-day access through telehealth remove the delay between deciding to seek help and actually receiving care, and that delay is where people get lost.
What to Try This Week
Call one MAT provider today. Ask two questions: whether they are state-licensed and accredited, and whether individual counseling is included in the program. That conversation tells you more than any website will. If both answers are yes, book the intake. The research is clear, the medications work, and a good program is built to keep you in it.